{
    "clinical_study": {
        "@rank": "115976", 
        "arm_group": {
            "arm_group_label": "gene expression profile", 
            "description": "T-Cell Receptor/B-Cell Receptor gene expression in cavity effusion is detected by micro-array to explore the mechanism that DC-CIK immunotherapy controls the malignant cavity effusion."
        }, 
        "brief_summary": {
            "textblock": "To investigate gene expression profile and immunological associated analysis relating to\n      immunotherapy response of patients with malignant tumor presenting malignant cavity effusion\n      after DC-CIK immunotherapy."
        }, 
        "brief_title": "Study of Gene Expression Profiling and Immunological Mechanism Affects the Response of Immunotherapy", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Malignant Tumor", 
        "condition_browse": {
            "mesh_term": "Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "1. The patients with malignant cavity effusion are treated with dendritic cells (DC) plus\n           cytokine induced killer cells (CIK) locally.\n\n        2. Malignant cavity effusion from cancer patients is obtained through puncture and is\n           centrifugalized to get supernatant fluid and enrich cancer cells before and after the\n           therapy.\n\n        3. The enriched cancer cells which are flash frozen, as well as the supernatant, are\n           stored at -80\u00b0C until processing.\n\n        4. The T-Cell Receptor/B-Cell Receptor gene expression in cavity effusion is detected by\n           micro-array to explore the mechanism that DC-CIK immunotherapy controls the malignant\n           cavity effusion.\n\n        5. Statistical analysis is performed using unsupervised hierarchical cluster."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Histologically confirmed with malignant tumor and malignant cavity effusion.\n\n          2. An Eastern Cooperative Oncology Group\uff08ECOG\uff09performance status of 0-2.\n\n          3. Normal cardiac, hepatic, renal and bone marrow functions.\n\n          4. Life expectancy >3 months.\n\n          5. Not receive other anti-tumor treatment.\n\n          6. Not receive chemotherapy in pleural and abdominal cavity.\n\n        Exclusion Criteria:\n\n          1. Previous history of other malignancies.\n\n          2. Serious or uncontrolled concurrent medical illness."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "The malignant tumor patients present with malignant cavity effusion and can receive DC-CIK\n        immunotherapy."
            }
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01884168", 
            "org_study_id": "GIMCEI"
        }, 
        "intervention": {
            "arm_group_label": "gene expression profile", 
            "description": "The patients with malignant cavity effusion are treated with dendritic cells (DC) plus cytokine induced killer cells (CIK) locally.", 
            "intervention_name": "Dc-CIK immunotherapy", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 19, 2013", 
        "location": {
            "contact": {
                "email": "renjun9688@yahoo.com", 
                "last_name": "Jun Ren, MD, PhD", 
                "phone": "86-10-63926317"
            }, 
            "facility": {
                "address": {
                    "city": "Beijing", 
                    "country": "China", 
                    "state": "Beijing", 
                    "zip": "100038"
                }, 
                "name": "Capital Medical University Cancer Center/Beijing Shijitan Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "1", 
        "official_title": "Gene Expression Profiling and Immunological Mechanism Affects the Response of Malignant Cavity Effusion Towards DC-CIK Immunotherapy", 
        "overall_contact": {
            "email": "renjun9688@yahoo.com", 
            "last_name": "Jun Ren, MD, PhD", 
            "phone": "86-10-63926317"
        }, 
        "overall_official": {
            "affiliation": "Capital Medical University  Cancer Center /Beijing Shijitan Hospital", 
            "last_name": "Jun Ren, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "T-Cell Receptor and B-Cell Receptor gene expression profiling and the change of cytokines, lymphocytes subpopulation before and after DC-CIK infusion", 
            "measure": "Immunotherapy response", 
            "safety_issue": "No", 
            "time_frame": "1 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01884168"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Capital Medical University", 
            "investigator_full_name": "Jun Ren MD, PhD", 
            "investigator_title": "Director", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Capital Medical University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Capital Medical University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "June 2013"
    }
}